Literature DB >> 1588650

Does blood transfusion or hemorrhagic shock induce immunosuppression?

J I Cué1, J C Peyton, M A Malangoni.   

Abstract

Blood transfusions have been implicated in predisposing patients to infection by inducing immunosuppression. This study evaluated the effects of syngeneic (ST) and allogeneic (AT) blood transfusion with and without hemorrhagic shock (HS) to determine whether transfusion or the accompanying hemorrhage affected certain components of the immune response. Lewis rats received ST or AT at 10%, 20%, or 30% of blood volume. Hemorrhagic shock was induced in other animals, which were resuscitated with either shed blood or substituted 10%, 20%, or 30% ST or AT. Intradermal staphylococcal abscess size, peritoneal leukocyte elicitation, and peritoneal macrophage Ia receptor expression were selected to measure the immune system response. Hemorrhagic shock increased abscess size significantly (p less than 0.05), but ST or AT alone or in combination with HS had no effect. Both shock and transfusion per se increased macrophage Ia receptor expression (p less than 0.05), but no additive or synergistic effect was observed. Peritoneal leukocyte elicitation was not affected by HS, ST, or AT. These results suggest that HS and not blood transfusion is a major determinant of the risk of infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588650     DOI: 10.1097/00005373-199205000-00013

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  2 in total

1.  Intraoperative blood transfusion contributes to decreased long-term survival of patients with esophageal cancer.

Authors:  Yoshihiro Komatsu; Hajime Orita; Mutsumi Sakurada; Hiroshi Maekawa; Toshitaka Hoppo; Koichi Sato
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

2.  Estimated intraoperative blood loss correlates with postoperative cardiopulmonary complications and length of stay in patients undergoing video-assisted thoracoscopic lung cancer lobectomy: a retrospective cohort study.

Authors:  Shuangjiang Li; Kun Zhou; Yutian Lai; Cheng Shen; Yanming Wu; Guowei Che
Journal:  BMC Surg       Date:  2018-05-23       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.